Bioventix (BVXP) Share Price, News & Analysis

Bioventix's stock was trading at GBX 4,300 at the beginning of the year. Since then, BVXP shares have increased by 5.6% and is now trading at GBX 4,542.
View the best growth stocks for 2024 here.

Bioventix PLC (LON:BVXP) posted its earnings results on Monday, March, 30th. The biotechnology company reported $69.28 earnings per share (EPS) for the quarter. Bioventix had a net margin of 63.73% and a trailing twelve-month return on equity of 79.14%.

Bioventix announced a dividend on Monday, March 25th. Shareholders of record on Thursday, April 11th will be paid a dividend of GBX 68 per share on Friday, April 26th. This represents a yield of 1.48%. The ex-dividend date is Thursday, April 11th. The official announcement can be accessed at this link.
Read our dividend analysis for BVXP.

Bioventix (LON:BVXP) pays an annual dividend of GBX 158 per share and currently has a dividend yield of 3.43%. The dividend payout ratio is 9,693.25%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for BVXP.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioventix investors own include Lancashire (LRE), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Entain PLC (GVC.L) (GVC), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS).

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.